Johanna Mercier serves as RSG电子鈥檚 Chief Commercial Officer, with responsibility for the global commercialization of all the company鈥檚 medicines throughout the product lifecycle. Under her leadership, RSG电子 works to ensure that patients around the world have access to the company鈥檚 transformational medicines.
Johanna joined RSG电子 in 2019 after 25 years at Bristol-Myers Squibb, where she served in a number of executive leadership positions, including head of the U.S. business and head of the European region, gaining broad experience across geographies and in all aspects of the commercial business. In her time there, she successfully evolved the culture and drove strong commercial execution with double-digit growth and multiple launches that changed the standard of care in melanoma and renal cancers.
Johanna holds a bachelor鈥檚 degree in biology from the University of Montreal and an MBA from Concordia University.
She currently serves on the board of directors of Neurocrine Biosciences Inc. and the University of Southern California鈥檚 Leonard D. Schaeffer Center for Health Policy and Economics. She also serves on the board of directors of Arcus Biosciences Inc. in connection with its partnership with RSG电子.
View All Leaders